The PhenoSense Integrase® assay is a phenotypic resistance test used to determine the susceptibility of a patient's HIV to integrase inhibitors. Integrase inhibitors block HIV replication by preventing the virus from integrating into the host cell's DNA. Raltegravir (Isentress®) is the first approved drug in this class of HIV antiretroviral drugs.
Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting
Do not send specimens until they are completely frozen, as nucleic acid degradation occurs rapidly at ambient and higher temperatures.
Specimen integrity is compromised with freeze/thaw cycles.
Frozen (strict)
Polymerase chain reaction (PCR) amplification and viral culture
See report